BioCardia, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioCardia, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q3 2024.
  • BioCardia, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $19K, a 20.8% decline year-over-year.
  • BioCardia, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $42K, a 17.6% decline year-over-year.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2023 was $73K.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2022 was -$6K, a 186% decline from 2021.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2021 was $7K, a 98.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $42K $19K -$5K -20.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $47K $3K -$25K -89.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $72K $8K -$1K -11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $73K $12K +$22K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $51K $24K +$21K +700% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $30K $28K +$29K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1K $9K +$7K +350% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$6K -$10K -$10K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $4K $3K +$1K +50% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3K -$1K -$3K -150% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $6K $2K -$1K -33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $7K $0 -$509K -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $516K $2K +$2K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $514K $2K +$1K +100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $513K $3K -$12K -80% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $525K $509K +$474K +1354% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $51K $0 +$565K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$514K $1K -$11K -91.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$503K $15K -$7K -31.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$496K $35K +$17K +94.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$513K -$565K -$591K -2273% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $78K $12K -$23K -65.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $101K $22K -$14K -38.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $115K $18K -$19K -51.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-09
Q3 2018 $134K $26K -$12K -31.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $146K $35K +$12K +52.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $134K $36K +$37K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $97K $37K +$147K Oct 1, 2017 Dec 31, 2017 10-K 2020-04-09
Q3 2017 -$50K $38K +$1.61M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$1.66M $23K +$623K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$2.28M -$1K +$419K +99.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$2.7M -$110K Oct 1, 2016 Dec 31, 2016 10-K 2019-04-02
Q3 2016 -$1.57M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$600K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$420K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.